.png)
In a 5-4 vote, the court ruled that the Sackler family cannot be shielded from future claims through Purdue’s bankruptcy. Since the case was first heard, victims of the opioid crisis and recovery advocates have been split on the desired outcome. Some wanted the bankruptcy deal to go through so that settlement money could start flowing and fund urgently needed addiction services. Others said it would be unacceptable to allow the Sacklers to evade responsibility for their actions.
The decision marks a significant victory for those seeking accountability for the opioid epidemic, as it means that Purdue Pharma will no longer be able to use its bankruptcy to avoid paying out settlements to victims and communities affected by their prescription drug marketing practices. The ruling came after years of legal battles and public pressure, with many advocates arguing that allowing the Sacklers to escape liability would only perpetuate the cycle of addiction and harm caused by their actions.
The court’s decision will likely have far-reaching consequences for both Purdue Pharma and the Sackler family, who have faced numerous lawsuits and investigations in recent years over their role in fueling the opioid epidemic. It remains to be seen how they will respond, but one thing is clear: The fight for justice and accountability in this matter is far from over.
